Cargando…

Significance of the suppression of blood glucose variability in acutely ill severe patients with glucose intolerance evaluated by means of bedside-type artificial pancreas

Detalles Bibliográficos
Autores principales:	Hoshino, M, Haraguchi, Y, Mizushima, I, Kajiwara, S, Takagi, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4088525/ http://dx.doi.org/10.1186/cc6375

Ejemplares similares

Investigation of insulin clearance in severely acutely ill patients with glucose intolerance evaluated by means of bedside-type artificial pancreas
por: Hoshino, M, et al.
Publicado: (2007)

Investigation of the blood glucose target for mortality reduction by means of bedside-type artificial pancreas
por: Hoshino, M, et al.
Publicado: (2011)

Significance of blood glucose variability in the early phase for predicting survival in acutely ill patients with glucose intolerance
por: Hoshino, M, et al.
Publicado: (2010)

Evaluation of glucose intolerance in acutely ill severe patients by means of an artificial pancreas
por: Hoshino, M, et al.
Publicado: (2004)

Relationship between blood glucose level and outcome in acutely ill severe patients with glucose intolerance evaluated by means of a bedside-type artificial pancreas
por: Hoshino, M, et al.
Publicado: (2006)

Influence of blood glucose-related factors to glucose tolerance in acutely ill severe patients evaluated by means of bedside-type artificial pancreas
por: Hoshino, M, et al.
Publicado: (2005)

High blood glucose variability in acute phase is one of the most important risk factors relating to the outcome in acutely ill severe patients with glucose intolerance
por: Hoshino, M, et al.
Publicado: (2009)

Influence of insulin clearance to glucose tolerance in acutely ill severe patients: analysis with glucose clamp method by means of artificial pancreas
por: Hoshino, M, et al.
Publicado: (2003)

Investigation of the factors which influence insulin sensitivity in septic patients with glucose intolerance: analysis with glucose clamp method by means of artificial pancreas
por: Hoshino, M, et al.
Publicado: (2002)

Investigation of insulin clearance in septic patients with glucose intolerance: analysis under strict blood glucose control by means of artificial pancreas
por: Hoshino, M, et al.
Publicado: (2001)

tPA-PAl (tissue plasminogen activator—plasminogen activator inhibitor-1 complex) can be a predictive marker of multiple organ dysfunction syndrome in seriously ill acute patients with glucose intolerance — analysis under strict blood glucose control by artificial pancreas
por: Hoshino, M, et al.
Publicado: (1999)

Close relationship of PAI-1 (plasminogen activator inhibitor-1) with multiple organ dysfunction syndrome and abnormal glucose metabolism investigated by means of artificial pancreas
por: Hoshino, M, et al.
Publicado: (1998)

Variable and maximum blood glucose levels during the first week after ICU admission are related to the severity of the patients
por: Hoshino, M, et al.
Publicado: (2012)

Blood glucose target in acute phase suggested by the analysis of the relationship between blood glucose profile and the severity of the diseases
por: Hoshino, M, et al.
Publicado: (2014)

FoxO1 Gain of Function in the Pancreas Causes Glucose Intolerance, Polycystic Pancreas, and Islet Hypervascularization
por: Kikuchi, Osamu, et al.
Publicado: (2012)

In Vivo JNK Activation in Pancreatic β-Cells Leads to Glucose Intolerance Caused by Insulin Resistance in Pancreas
por: Lanuza-Masdeu, Jordi, et al.
Publicado: (2013)

Hypercoagulability indicated by elevated blood TFPI (tissue factor pathway inhibitor) levels is closely related to severity of septic patients with glucose intolerance
por: Hoshino, M, et al.
Publicado: (2000)

Close relationship of tissue plasminogen activator-plasminogen activator inhibitor-1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas
por: Hoshino, Masami, et al.
Publicado: (2001)

Proinsulin is sensitive to reflect glucose intolerance
por: Nakamura, Akinobu, et al.
Publicado: (2019)

Oral Limonite Supplement Ameliorates Glucose Intolerance in Diabetic and Obese Mice
por: Uchida, Akihiro, et al.
Publicado: (2021)

Unannounced Meals in the Artificial Pancreas: Detection Using Continuous Glucose Monitoring
por: Ramkissoon, Charrise M., et al.
Publicado: (2018)

Continuous Glucose Monitoring in Patients Following Simultaneous Pancreas–Kidney Transplantation: Time in Range and Glucose Variability
por: Dmitriev, Ilya V., et al.
Publicado: (2023)

Blood glucose variability, measured as mean absolute glucose, strongly depends on the frequency of blood glucose level measurements
por: Harmsen, RE, et al.
Publicado: (2011)

Newly diagnosed glucose intolerance and prognosis after acute myocardial infarction: comparison of post-challenge versus fasting glucose concentrations
por: Tamita, Koichi, et al.
Publicado: (2012)

Blueberries’ Impact on Insulin Resistance and Glucose Intolerance
por: Stull, April J.
Publicado: (2016)

METABOLIC SYNDROME, GLUCOSE INTOLERANCE, AND PHYSICAL RESILIENCE
por: Kalyani, Rita, et al.
Publicado: (2022)

Determinants of Impaired Fasting Glucose Versus Glucose Intolerance in Polycystic Ovary Syndrome
por: Karakas, Sidika E., et al.
Publicado: (2010)

Glucose Homeostatic Law: Insulin Clearance Predicts the Progression of Glucose Intolerance in Humans
por: Ohashi, Kaoru, et al.
Publicado: (2015)

Predicting glucose intolerance with normal fasting plasma glucose by the components of the metabolic syndrome
por: Pei, Dee, et al.
Publicado: (2007)

Validity of bedside blood glucose measurement in critically ill patients with intensive insulin therapy
por: Mahmoodpoor, Ata, et al.
Publicado: (2016)

Risk of Glucose Intolerance and Diabetes in Hemipancreatectomized Donors Selected for Normal Preoperative Glucose Metabolism
por: Kumar, Anjali F., et al.
Publicado: (2008)

Muscle-specific TGR5 overexpression improves glucose clearance in glucose-intolerant mice
por: Sasaki, Takashi, et al.
Publicado: (2020)

Impact of real-time continuous glucose monitoring on glucose variability in critically ill patients
por: Brunner, R, et al.
Publicado: (2010)

Performance and safety of an integrated bihormonal artificial pancreas for fully automated glucose control at home
por: Blauw, H., et al.
Publicado: (2016)

Metformin and Cancer Glucose Metabolism: At the Bench or at the Bedside?
por: Marini, Cecilia, et al.
Publicado: (2021)

Sox9-Haploinsufficiency Causes Glucose Intolerance in Mice
por: Dubois, Claire L., et al.
Publicado: (2011)

Exenatide improves glucocorticoid-induced glucose intolerance in mice
por: Zhao, Ruiying, et al.
Publicado: (2011)

Fat Distribution and Glucose Intolerance Among Greenland Inuit
por: Jørgensen, Marit Eika, et al.
Publicado: (2013)

Intestinal Ralstonia pickettii augments glucose intolerance in obesity
por: Udayappan, Shanthadevi D., et al.
Publicado: (2017)

Fasting and rapamycin: diabetes versus benevolent glucose intolerance
por: Blagosklonny, Mikhail V.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5k1eh0iru26bm0b35960vd5c17